Aqemia helps drug research

The Aqemia nugget has developed software capable of predicting the affinity between drug candidates and the therapeutic targets responsible for diseases. Maximilien Levesque, its managing director and co-founder, affirms that this software is able to make a prediction in a few minutes, against a few days usually.


See also  Lessons learned by the EU from the public health crisis linked to COVID-19 | News